FDA Watch: Agency Issues New Guidance on Biotin Interference Testing

 Email not displaying correctly? View it in your browser.
  Lab and Pathology Insider Logo  
September 4, 2019  
placeholder FDA
FDA Watch: Agency Issues New Guidance on Biotin Interference Testing
From Diagnostic Testing & Emerging Technologies
On June 13, the FDA issued a draft guidance explaining how makers of in vitro diagnostic devices (IVDs) should perform…
Read More
placeholder FEE SCHEDULES
Medicare Reimbursement: CMS Publishes New CPT Codes
From National Intelligence Report
CMS recently published new CPT codes taking effect on Oct. 1, 2019. All the codes have a Type of Service (TOS) code of 5, and the codes are…
Read More
placeholder INDUSTRY BUZZ
FDA Watch: Agency Okays EIA Technology-Based Lyme Assays
From Laboratory Industry Report
Laboratory diagnosis of Lyme disease is based on detecting the presence of antibodies against…
Read More
placeholder OPERATIONS
Lab Management: Billing Company Contract Liability Risks & How to Avoid Them
From Lab Compliance Advisor
Like many labs, you may outsource your billing and coding to an outside medical billing company. While this…
Read More
placeholder LAB OPERATIONS
Earning our Spot on the Patient-Centered Care Team
From G2 Blog
There is a lot of talk these days about integrating the laboratory into patient-centered care teams…
Read More

For questions concerning delivery of this email, please contact customer service at:
(888) 729-2315 | customerservice@plainlanguagemedia.com

Copyright © 2019, All rights reserved.
Plain Language Media LLLP
PO Box 509, New London, CT 06320